Lung Carcinoma (NSCLC) Profile Test in Turbhe
50+ booked in last 3 daysOverview
Targeted cancer therapies are defined as antibody or small molecule drugs that block the growth and spread of cancer by interfering with specific cell molecules involved in tumor growth and progression.
Summary Price Of Lung Carcinoma (NSCLC) Profile Test in Turbhe
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Lung Carcinoma (NSCLC) Profile Test with a clear pricing structure
The price of Lung Carcinoma (NSCLC) Profile Test in Turbhe is ₹ 11,500
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
To make an online appointment, get in touch with Metropolis.
Frequently Asked Questions
Identifying lung tumors that may respond to targeted therapies by simultaneously assessing multiple genes involved in rearrangements.
Your doctor may suggest to Identify lung tumors that may respond to targeted therapies.
Targeted cancer therapies are defined as antibody or small molecule drugs that block the growth and spread of cancer by interfering with specific cell molecules involved in tumor growth and progression. Multiple targeted therapies have been approved by the FDA for treatment of specific cancers. Molecular genetic profiling is often needed to identify targets amenable to targeted therapies and to minimize treatment costs and therapy-associated risks.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.